Krawczyk, P., Kowalski, D. M., Ramlau, R., Kalinka-Warzocha, E., Winiarczyk, K., Stencel, K., . . . Krzakowski, M. (2017). Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations. Oncol Lett.
Citação norma ChicagoKrawczyk, Pawel, et al. "Comparison of the Effectiveness of Erlotinib, Gefitinib, and Afatinib for Treatment of Non-small Cell Lung Cancer in Patients With Common and Rare EGFR Gene Mutations." Oncol Lett 2017.
Citação norma MLAKrawczyk, Pawel, et al. "Comparison of the Effectiveness of Erlotinib, Gefitinib, and Afatinib for Treatment of Non-small Cell Lung Cancer in Patients With Common and Rare EGFR Gene Mutations." Oncol Lett 2017.